Cited 8 time in
Comparison Between Ultrasonography and Galactography in Detecting Lesions in Patients With Pathologic Nipple Discharge
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jung, Hyun Kyung | - |
| dc.contributor.author | Park, Young Mi | - |
| dc.contributor.author | Baek, Hye Jin | - |
| dc.contributor.author | Choo, Hye Jung | - |
| dc.contributor.author | Kim, Eun-Kyung | - |
| dc.contributor.author | Kim, Dong Wook | - |
| dc.contributor.author | Lee, Sun Joo | - |
| dc.contributor.author | Lee, Jin Hwa | - |
| dc.date.accessioned | 2022-12-26T15:05:16Z | - |
| dc.date.available | 2022-12-26T15:05:16Z | - |
| dc.date.issued | 2019-03 | - |
| dc.identifier.issn | 0894-8771 | - |
| dc.identifier.issn | 1536-0253 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/9408 | - |
| dc.description.abstract | Purpose This study aimed to compare the diagnostic performance of breast ultrasonography (US) with that of galactography in the detection of lesions in patients with pathologic nipple discharge. Methods We included 46 cases from 39 patients (all women; mean age, 44.0 years; range, 22-68 years) who had pathologic nipple discharge and underwent US and galactography between March 2004 and December 2012. Two radiologists retrospectively reviewed and compared the detectability of lesions on US and galactography images. A receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance of US and galactography, and the area under the curve was compared between the 2 imaging modalities. Results A total of 35 cases were pathologically diagnosed. Out of 11 cases that completed a follow-up, none developed malignancies during the follow-up period (mean: 63.5 months; range: 34.8-125.7 months). The sensitivity, specificity, and positive and negative predictive values of US with respect to detectability of lesions were 75%, 42.9%, 11.1%, and 94.7%, respectively, and those of galactography were 100%, 38.1%, 13.3%, and 100%, respectively. Conclusions Galactography is more sensitive than US in the detection of lesions in patients with pathologic nipple discharge. | - |
| dc.format.extent | 6 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Lippincott Williams & Wilkins Ltd. | - |
| dc.title | Comparison Between Ultrasonography and Galactography in Detecting Lesions in Patients With Pathologic Nipple Discharge | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1097/RUQ.0000000000000365 | - |
| dc.identifier.scopusid | 2-s2.0-85062525962 | - |
| dc.identifier.wosid | 000461568900016 | - |
| dc.identifier.bibliographicCitation | Ultrasound Quarterly, v.35, no.1, pp 93 - 98 | - |
| dc.citation.title | Ultrasound Quarterly | - |
| dc.citation.volume | 35 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 93 | - |
| dc.citation.endPage | 98 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
| dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
| dc.subject.keywordPlus | DIAGNOSTIC-VALUE | - |
| dc.subject.keywordPlus | BREAST | - |
| dc.subject.keywordPlus | SONOGRAPHY | - |
| dc.subject.keywordAuthor | breast | - |
| dc.subject.keywordAuthor | ultrasonography | - |
| dc.subject.keywordAuthor | galactography | - |
| dc.subject.keywordAuthor | nipple discharge | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
